Recent Drug Development Research for December 2024
Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Neurofibromatoses Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Kidney Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Renal
| Chronic Kidney Disease (Chronic Renal Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Renal
| Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Allergic Conditions, Drug Discovery, Allergy/Immunology
| Klebsiella Pneumoniae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Hepatitis, Drug Discovery
| Measles Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Infectious Diseases
| Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Adenosine Receptor A3 (ADORA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Clinical Trial
| Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)
Topics: Research & Development, Instrumentation & Equipment, Drug Development
Regions: Global
| Drug Discovery Informatics Market Report 2021-2031
Topics: Informatics, Drug Development, Drug Discovery
Regions: Global
| Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032
Topics: Research & Development, Drug Development, Internet of Things IoT, Drug Discovery, Cardiovascular, Infectious Diseases
Regions: Global
| Drug Discovery Services Market Report 2022-2032
Topics: Drug Development, AIDS, HIV & STDs, Cancer Treatment, Drug Discovery
| 2022 Global: Drug Discovery Informatics - Innovative Markets Forecast (2028) report
Topics: Informatics, Drug Development, Drug Discovery
Regions: Global
| Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Sedation (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Fibromyalgia (Fibromyalgia Syndrome) (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Pain, Drug Discovery, CNS/Neurology
| Alcohol Addiction (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Hyperalgesia (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) - Drugs in Development, 2021
Topics: Drug Development, Allergic Conditions, Drug Discovery
| Otitis Media (Ear Nose Throat Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Colitis (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021
Topics: Drug Development, Manufacturing, Packaging & Detailing, Drug Discovery, Gastrointestinal
| Down Syndrome (Genetic Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Iron Deficiency Anemia (Hematology) - Drugs in Development, 2021
Topics: Drug Development, Blood Diseases, Drug Discovery, Oncology/Hematology
| Secondary Hyperparathyroidism (Hormonal Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Allergy/Immunology
| House Dust Mite Allergy (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Allergy/Immunology
| Lyme Disease (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Lyme Disease, Drug Discovery
| Typhoid Fever (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Infectious Diseases
| Cholera (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Infectious Diseases
| Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Plague (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
